Bavencio
Bavencio Receives New Indication for Maintenance in Advanced Urothelial Carcinoma
The FDA granted a new indication for avelumab for the maintenance treatment of patients with locally advanced or ...
JULY 6, 2020
FDA Approves Bavencio With Inlyta for Patients With Advanced Renal Cell Cancer
Bavencio with Inlyta is the first FDA approval for an anti–PD-L1 therapy as part of a combination regimen for ...
MAY 16, 2019
Load more